Exact Mass: 377.1659

Exact Mass Matches: 377.1659

Found 183 metabolites which its exact mass value is equals to given mass value 377.1659, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Imidaprilat

(4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-carboxy-3-phenylpropyl)amino]propionyl}-2-oxo-imidazolidine-4-carboxylic acid

C18H23N3O6 (377.1587)


Imidaprilat, is the active metabolite of Imidapril. Imidapril is a prodrug used to treat hypertension, chronic congestive heart failure (CHF), acute myocardial infarction (AMI), and diabetic nephropathy (PMID: 17547476,18192036,12177688, 17094051). Imidapril belongs to a class of long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitors (PMID: 8851752, 12177688). Imidaprilat competitively binds and inhibits the catalytic activity of ACE, which results in a reduction of peripheral resistance and a reduction in systemic blood pressure (BP) (PMID: 17547476). Imidaprilat is only found in individuals that have used or taken imidapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

7-[(3S,4S)-3-(Benzenesulphonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

C20H27NO4S (377.1661)


   

3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid

3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid

C18H23N3O6 (377.1587)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors

   

Sulfinalol

4-(1-Hydroxy-2-{[4-(4-methoxyphenyl)butan-2-yl]amino}ethyl)-2-methanesulphinylphenol

C20H27NO4S (377.1661)


   

Talarozole

N-{4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine

C21H23N5S (377.1674)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

(3E,6Z)-3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione

(3E,6Z)-3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione

C22H23N3O3 (377.1739)


   

Ficuseptine B

Ficuseptine B

C23H23NO4 (377.1627)


   

Atalaphillinine

Atalaphillinine

C23H23NO4 (377.1627)


   

cycloatalaphylline A

cycloatalaphylline A

C23H23NO4 (377.1627)


   
   

UNII-K9H6459WGA

UNII-K9H6459WGA

C24H21F2NO (377.1591)


   
   

6-methoxy-11,12,13,14,14a,15-hexahydro-9H-benzo[h][1,3]dioxolo[4,5:4,5]benzo[1,2-f]pyrido[1,2-b]isoquinolin-12-ol|Cryptopleuridin|Cryptopleuridine

6-methoxy-11,12,13,14,14a,15-hexahydro-9H-benzo[h][1,3]dioxolo[4,5:4,5]benzo[1,2-f]pyrido[1,2-b]isoquinolin-12-ol|Cryptopleuridin|Cryptopleuridine

C23H23NO4 (377.1627)


   

waltherione A

waltherione A

C23H23NO4 (377.1627)


   
   
   

cysteylglutaminyllysine

cysteylglutaminyllysine

C14H27N5O5S (377.1733)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ala Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C14H27N5O5S (377.1733)


   

Ala Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C14H27N5O5S (377.1733)


   

Ala Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S (377.1733)


   

Ala Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Ala Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S (377.1733)


   

Ala Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Cys Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]acetamido}hexanoic acid

C14H27N5O5S (377.1733)


   

Cys Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]acetic acid

C14H27N5O5S (377.1733)


   

Cys Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}propanamido]hexanoic acid

C14H27N5O5S (377.1733)


   

Cys Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]propanoic acid

C14H27N5O5S (377.1733)


   

Cys Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]acetic acid

C14H27N5O5S (377.1733)


   

Cys Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}propanoic acid

C14H27N5O5S (377.1733)


   

Gly Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S (377.1733)


   

Gly Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Gly Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]propanamido]hexanoic acid

C14H27N5O5S (377.1733)


   

Gly Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]propanoic acid

C14H27N5O5S (377.1733)


   

Gly Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Gly Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]propanoic acid

C14H27N5O5S (377.1733)


   
   
   

Lys Ala Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S (377.1733)


   

Lys Ala Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Lys Cys Ala Gly

2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]acetic acid

C14H27N5O5S (377.1733)


   

Lys Cys Gly Ala

(2S)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}propanoic acid

C14H27N5O5S (377.1733)


   
   
   

Lys Gly Ala Cys

(2R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-sulfanylpropanoic acid

C14H27N5O5S (377.1733)


   

Lys Gly Cys Ala

(2S)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]propanoic acid

C14H27N5O5S (377.1733)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Imidaprilat

(4S)-3-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid

C18H23N3O6 (377.1587)


A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

[4-(3-Methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-1,2-oxazol- 4-yl)methanone

[4-(3-Methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-1,2-oxazol- 4-yl)methanone

C22H23N3O3 (377.1739)


   

1,3,3-trimethyl-2-[(methyl-2-naphthylhydrazono)methyl]-3H-indolium chloride

1,3,3-trimethyl-2-[(methyl-2-naphthylhydrazono)methyl]-3H-indolium chloride

C23H24ClN3 (377.1659)


   

3-AMINO-3-(3,4-DIBENZYLOXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(3,4-DIBENZYLOXY-PHENYL)-PROPIONIC ACID

C23H23NO4 (377.1627)


   

fenetylline hydrochloride

fenetylline hydrochloride

C18H24ClN5O2 (377.1618)


   

3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride

3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride

C19H25BClNO4 (377.1565)


   

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-methoxyphenyl)- (9CI)

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-methoxyphenyl)- (9CI)

C22H23N3O3 (377.1739)


   

2-Dodecylisoquinolinium bromide

2-Dodecylisoquinolinium bromide

C21H32BrN (377.1718)


   

dibutyl [[(diethylamino)thioxomethyl]thio]succinate

dibutyl [[(diethylamino)thioxomethyl]thio]succinate

C17H31NO4S2 (377.1694)


   

Methanone, [4-(4-methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-

Methanone, [4-(4-methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-

C22H23N3O3 (377.1739)


   

Sulfinalol

Sulfinalol

C20H27NO4S (377.1661)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   
   

Propafenone hydrochloride

Propafenone hydrochloride

C21H28ClNO3 (377.1758)


D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565)


   

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565)


   

(R)-Talarozole

Talarozole (R enantiomer)

C21H23N5S (377.1674)


   
   

Setiptiline maleate

Setiptiline (maleate)

C23H23NO4 (377.1627)


Setiptiline maleate (MO-8282 maleate) is a serotonin receptor antagonist. Setiptiline maleate is a tetracyclic antidepressant (TeCA) which acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). Setiptiline maleate acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, as well as an H1 receptor inverse agonist/antihistamine[1][2][3][4].

   

Domitroban

7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

C20H27NO4S (377.1661)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

AC-BETA-(2-THIENYL)-ALA-OH

AC-BETA-(2-THIENYL)-ALA-OH

C23H23NO4 (377.1627)


   

tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H25BClNO4 (377.1565)


   

5-ethyl-5,10-dihydro-10,10-diphenylphenosilazine

5-ethyl-5,10-dihydro-10,10-diphenylphenosilazine

C26H23NSi (377.16)


   

N-Fmoc-2-amino-2-(2-propenyl)-4-Pentenoic acid

N-Fmoc-2-amino-2-(2-propenyl)-4-Pentenoic acid

C23H23NO4 (377.1627)


   

3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione

3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione

C22H23N3O3 (377.1739)


   

2-[2-Amino-5-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol

2-[2-Amino-5-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol

C22H23N3O3 (377.1739)


   

5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one

5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one

C22H23N3O3 (377.1739)


   

Diethylaminoethyl diphenylhydroxypropionate hydrochloride

Diethylaminoethyl diphenylhydroxypropionate hydrochloride

C21H28ClNO3 (377.1758)


   

(3s)-1-(1,3-Benzodioxol-5-Ylmethyl)-3-[4-(1h-Imidazol-1-Yl)phenoxy]piperidine

(3s)-1-(1,3-Benzodioxol-5-Ylmethyl)-3-[4-(1h-Imidazol-1-Yl)phenoxy]piperidine

C22H23N3O3 (377.1739)


   

2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide

2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide

C22H23N3O3 (377.1739)


   

Talarozole

Talarozole

C21H23N5S (377.1674)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

Protuboxepin A

Protuboxepin A

C22H23N3O3 (377.1739)


An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and a butan-2-yl group at position 11. It has been isolated from Aspergillus species.

   

3-methoxy-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]benzamide

3-methoxy-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]benzamide

C22H23N3O3 (377.1739)


   

(S)-talarozole

(S)-talarozole

C21H23N5S (377.1674)


   

1-(2-Methoxyphenyl)-4-{[5-(4-methylphenyl)-3-isoxazolyl]carbonyl}piperazine

1-(2-Methoxyphenyl)-4-{[5-(4-methylphenyl)-3-isoxazolyl]carbonyl}piperazine

C22H23N3O3 (377.1739)


   

1-(3-Chlorophenyl)-3-(9-cyclopentyl-9-azabicyclo[3.3.1]nonan-3-yl)thiourea

1-(3-Chlorophenyl)-3-(9-cyclopentyl-9-azabicyclo[3.3.1]nonan-3-yl)thiourea

C20H28ClN3S (377.1692)


   

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone

C22H23N3OS (377.1562)


   

N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide

N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide

C22H23N3O3 (377.1739)


   
   
   
   
   
   
   

(1R,5S)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H23N3O3 (377.1739)


   

(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

(6R,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole

2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole

C22H23N3OS (377.1562)


   

(1S,5R)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1S,5R)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H23N3O3 (377.1739)


   

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   

(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C22H23N3O3 (377.1739)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

ethyl 2-[(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate

ethyl 2-[(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate

C22H23N3O3 (377.1739)


   

(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one

(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one

C22H23N3OS (377.1562)


   

Co 101244 (hydrochloride)

Co 101244 (hydrochloride)

C21H28ClNO3 (377.1758)


Co 101244 (PD 174494) hydrochloride is a NR2B-containing NMDA receptor antagonist[1].

   

(23r)-12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

(23r)-12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

C23H23NO4 (377.1627)


   

(1s,4r)-4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one

(1s,4r)-4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one

C22H23N3O3 (377.1739)


   

(1s,12r,13r)-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one

(1s,12r,13r)-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one

C23H23NO4 (377.1627)


   

5,10-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-11h-1-oxa-11-azatetracen-6-one

5,10-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-11h-1-oxa-11-azatetracen-6-one

C23H23NO4 (377.1627)


   

(21r,24s)-13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol

(21r,24s)-13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol

C23H23NO4 (377.1627)


   

(1r,13s,14s,16r,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate

(1r,13s,14s,16r,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate

C22H23N3O3 (377.1739)


   

12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

C23H23NO4 (377.1627)


   

13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol

13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol

C23H23NO4 (377.1627)


   

(1r,13s,14s,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate

(1r,13s,14s,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate

C22H23N3O3 (377.1739)


   

(4s,7r)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4s,7r)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C22H23N3O3 (377.1739)


   

4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one

4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one

C22H23N3O3 (377.1739)


   

(4r,7s)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4r,7s)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C22H23N3O3 (377.1739)


   

6,11-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-5h-1-oxa-5-azatetraphen-10-one

6,11-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-5h-1-oxa-5-azatetraphen-10-one

C23H23NO4 (377.1627)


   

7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C22H23N3O3 (377.1739)